{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:27:29Z","timestamp":1791073649638,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,7,25]],"date-time":"2004-07-25T00:00:00Z","timestamp":1090713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1038\/nm1086","type":"journal-article","created":{"date-parts":[[2004,7,25]],"date-time":"2004-07-25T17:27:56Z","timestamp":1090776476000},"page":"835-841","source":"Crossref","is-referenced-by-count":83,"title":["Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency"],"prefix":"10.1038","volume":"10","author":[{"given":"Minoru","family":"Tahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G","family":"Pergolizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsta","family":"Luettich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L","family":"Lesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,7,25]]},"reference":[{"key":"BFnm1086_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/0167-5699(93)90188-Q","volume":"14","author":"RE Callard","year":"1993","unstructured":"Callard, R.E., Armitage, R.J., Fanslow, W.C. & Spriggs, M.K. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 14, 559\u2013564 (1993).","journal-title":"Immunol. Today"},{"key":"BFnm1086_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1600-065X.1994.tb00846.x","volume":"138","author":"RA Kroczek","year":"1994","unstructured":"Kroczek, R.A. et al. Defective expression of CD40 ligand on T cells causes \u201cX-linked immunodeficiency with hyper-IgM (HIGM1)\u201d. Immunol. Rev. 138, 39\u201359 (1994).","journal-title":"Immunol. Rev."},{"key":"BFnm1086_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/361541a0","volume":"361","author":"JP Di Santo","year":"1993","unstructured":"Di Santo, J.P., Bonnefoy, J.Y., Gauchat, J.F., Fischer, A. & de Saint, B.G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361, 541\u2013543 (1993).","journal-title":"Nature"},{"key":"BFnm1086_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/361539a0","volume":"361","author":"U Korthauer","year":"1993","unstructured":"Korthauer, U. et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361, 539\u2013541 (1993).","journal-title":"Nature"},{"key":"BFnm1086_CR5","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.4049\/jimmunol.151.5.2497","volume":"151","author":"M Roy","year":"1993","unstructured":"Roy, M., Waldschmidt, T., Aruffo, A., Ledbetter, J.A. & Noelle, R.J. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J. Immunol. 151, 2497\u20132510 (1993).","journal-title":"J. Immunol."},{"key":"BFnm1086_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4049\/jimmunol.156.1.8","volume":"156","author":"RD Stout","year":"1996","unstructured":"Stout, R.D., Suttles, J., Xu, J., Grewal, I.S. & Flavell, R.A. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156, 8\u201311 (1996).","journal-title":"J. Immunol."},{"key":"BFnm1086_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","volume":"16","author":"IS Grewal","year":"1998","unstructured":"Grewal, I.S. & Flavell, R.A. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16, 111\u2013135 (1998).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnm1086_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4049\/jimmunol.170.2.727","volume":"170","author":"AD Straw","year":"2003","unstructured":"Straw, A.D., MacDonald, A.S., Denkers, E.Y. & Pearce, E.J. CD154 plays a central role in regulating dendritic cell activation during infections that induce Th1 or Th2 responses. J. Immunol. 170, 727\u2013734 (2003).","journal-title":"J. Immunol."},{"key":"BFnm1086_CR9","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1182\/blood-2003-06-2014","volume":"103","author":"AR Gennery","year":"2004","unstructured":"Gennery, A.R. et al. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002. Blood 103, 1152\u20131157 (2004).","journal-title":"Blood"},{"key":"BFnm1086_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","volume":"131","author":"J Levy","year":"1997","unstructured":"Levy, J. et al. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. 131, 47\u201354 (1997).","journal-title":"J. Pediatr."},{"key":"BFnm1086_CR11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJM200002033420504","volume":"342","author":"N Hadzic","year":"2000","unstructured":"Hadzic, N. et al. Correction of the hyper-IgM syndrome after liver and bone marrow transplantation. N. Engl. J. Med. 342, 320\u2013324 (2000).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1086_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1056\/NEJM199508173330705","volume":"333","author":"C Thomas","year":"1995","unstructured":"Thomas, C. et al. Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. N. Engl. J. Med. 333, 426\u2013429 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1086_CR13","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/3233","volume":"4","author":"MP Brown","year":"1998","unstructured":"Brown, M.P. et al. Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nat. Med. 4, 1253\u20131260 (1998).","journal-title":"Nat. Med."},{"key":"BFnm1086_CR14","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/sj.cgt.7700232","volume":"7","author":"MG Sacco","year":"2000","unstructured":"Sacco, M.G. et al. Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome. Cancer Gene Ther. 7, 1299\u20131306 (2000).","journal-title":"Cancer Gene Ther."},{"key":"BFnm1086_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1172\/JCI200319419","volume":"112","author":"BA Sullenger","year":"2003","unstructured":"Sullenger, B.A. Targeted genetic repair: an emerging approach to genetic therapy. J. Clin. Invest. 112, 310\u2013311 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnm1086_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/6986","volume":"17","author":"M Puttaraju","year":"1999","unstructured":"Puttaraju, M., Jamison, S.F., Mansfield, S.G., Garcia-Blanco, M.A. & Mitchell, L.G. Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nat. Biotechnol. 17, 246\u2013252 (1999).","journal-title":"Nat. Biotechnol."},{"key":"BFnm1086_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1163\/156855800744584","volume":"1","author":"MA Garcia-Blanco","year":"2000","unstructured":"Garcia-Blanco, M.A., Puttaraju, M., Mansfield, S.G. & Mitchell, L.G. Spliceosome-mediated RNA trans-splicing in gene therapy and genomics. Gene Ther. Regul. 1, 141\u2013163 (2000).","journal-title":"Gene Ther. Regul."},{"key":"BFnm1086_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nbt0102-47","volume":"20","author":"X Liu","year":"2002","unstructured":"Liu, X. et al. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat. Biotechnol. 20, 47\u201352 (2002).","journal-title":"Nat. Biotechnol."},{"key":"BFnm1086_CR19","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/sj.gt.3301307","volume":"7","author":"SG Mansfield","year":"2000","unstructured":"Mansfield, S.G. et al. Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing. Gene Ther. 7, 1885\u20131895 (2000).","journal-title":"Gene Ther."},{"key":"BFnm1086_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1006\/mthe.2001.0426","volume":"4","author":"M Puttaraju","year":"2001","unstructured":"Puttaraju, M., Di Pasquale, J., Baker, C.C., Mitchell, L.G. & Garcia-Blanco, M.A. Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing. Mol. Ther. 4, 105\u2013114 (2001).","journal-title":"Mol. Ther."},{"key":"BFnm1086_CR21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nm900","volume":"9","author":"H Chao","year":"2003","unstructured":"Chao, H. et al. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing. Nat. Med. 9, 1015\u20131019 (2003).","journal-title":"Nat. Med."},{"key":"BFnm1086_CR22","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1172\/JCI200319462","volume":"112","author":"MA Garcia-Blanco","year":"2003","unstructured":"Garcia-Blanco, M.A. Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing. J. Clin. Invest. 112, 474\u2013480 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnm1086_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1096\/fasebj.7.1.8422973","volume":"7","author":"L Bonen","year":"1993","unstructured":"Bonen, L. Trans-splicing of pre-mRNA in plants, animals, and protists. FASEB J. 7, 40\u201346 (1993).","journal-title":"FASEB J."},{"key":"BFnm1086_CR24","doi-asserted-by":"publisher","first-page":"12185","DOI":"10.1073\/pnas.95.21.12185","volume":"95","author":"C Caudevilla","year":"1998","unstructured":"Caudevilla, C. et al. Natural trans-splicing in carnitine octanoyltransferase pre-mRNAs in rat liver. Proc. Natl. Acad. Sci. USA 95, 12185\u201312190 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1086_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/1074-7613(94)90073-6","volume":"1","author":"J Xu","year":"1994","unstructured":"Xu, J. et al. Mice deficient for the CD40 ligand. Immunity. 1, 423\u2013431 (1994).","journal-title":"Immunity."},{"key":"BFnm1086_CR26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0167-5699(94)90193-7","volume":"15","author":"R Testi","year":"1994","unstructured":"Testi, R., D'Ambrosio, D., De Maria, R. & Santoni, A. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15, 479\u2013483 (1994).","journal-title":"Immunol. Today"},{"key":"BFnm1086_CR27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1165\/ajrcmb\/8.4.370","volume":"8","author":"JK Kolls","year":"1993","unstructured":"Kolls, J.K., Beck, J.M., Nelson, S., Summer, W.R. & Shellito, J. Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia. Am. J. Respir. Cell Mol. Biol. 8, 370\u2013376 (1993).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFnm1086_CR28","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.4049\/jimmunol.162.5.2890","volume":"162","author":"JK Kolls","year":"1999","unstructured":"Kolls, J.K. et al. IFN-\u03b3 and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells. J. Immunol. 162, 2890\u20132894 (1999).","journal-title":"J. Immunol."},{"key":"BFnm1086_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0958-1669(02)00346-4","volume":"13","author":"AC Logan","year":"2002","unstructured":"Logan, A.C., Lutzko, C. & Kohn, D.B. Advances in lentiviral vector design for gene-modification of hematopoietic stem cells. Curr. Opin. Biotechnol. 13, 429\u2013436 (2002).","journal-title":"Curr. Opin. Biotechnol."},{"key":"BFnm1086_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1006\/mpat.2002.0528","volume":"33","author":"R Baumgartner","year":"2002","unstructured":"Baumgartner, R. et al. Evidence for the requirement of T cell costimulation in the pathogenesis of natural Pneumocystis carinii pulmonary infection. Microb. Pathog. 33, 193\u2013201 (2002).","journal-title":"Microb. Pathog."},{"key":"BFnm1086_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1074-7613(00)80436-7","volume":"4","author":"KA Campbell","year":"1996","unstructured":"Campbell, K.A. et al. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4, 283\u2013289 (1996).","journal-title":"Immunity"},{"key":"BFnm1086_CR32","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.4049\/jimmunol.168.9.4643","volume":"168","author":"AS MacDonald","year":"2002","unstructured":"MacDonald, A.S. et al. Impaired Th2 development and increased mortality during Schistosoma mansoni infection in the absence of CD40\/CD154 interaction. J. Immunol. 168, 4643\u20134649 (2002).","journal-title":"J. Immunol."},{"key":"BFnm1086_CR33","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/1521-4141(200205)32:5<1455::AID-IMMU1455>3.0.CO;2-C","volume":"32","author":"MG Netea","year":"2002","unstructured":"Netea, M.G., Meer, J.W., Verschueren, I. & Kullberg, B.J. CD40\/CD40 ligand interactions in the host defense against disseminated Candida albicans infection: the role of macrophage-derived nitric oxide. Eur. J. Immunol. 32, 1455\u20131463 (2002).","journal-title":"Eur. J. Immunol."},{"key":"BFnm1086_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1074-7613(00)80434-3","volume":"4","author":"L Soong","year":"1996","unstructured":"Soong, L. et al. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4, 263\u2013273 (1996).","journal-title":"Immunity"},{"key":"BFnm1086_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hep.510300138","volume":"30","author":"J Stephens","year":"1999","unstructured":"Stephens, J., Cosyns, M., Jones, M. & Hayward, A. Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice. Hepatology 30, 27\u201335 (1999).","journal-title":"Hepatology"},{"key":"BFnm1086_CR36","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.4049\/jimmunol.161.9.4583","volume":"161","author":"AR Thomsen","year":"1998","unstructured":"Thomsen, A.R., Nansen, A., Christensen, J.P., Andreasen, S.O. & Marker, O. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. J. Immunol. 161, 4583\u20134590 (1998).","journal-title":"J. Immunol."},{"key":"BFnm1086_CR37","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1128\/AAC.39.7.1442","volume":"39","author":"S Merali","year":"1995","unstructured":"Merali, S., Chin, K., Grady, R.W., Weissberger, L. & Clarkson, A.B. Response of rat model of Pneumocystis carinii pneumonia to continuous infusion of deferoxamine. Antimicrob. Agents Chemother. 39, 1442\u20131444 (1995).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnm1086_CR38","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1172\/JCI13826","volume":"108","author":"M Zheng","year":"2001","unstructured":"Zheng, M. et al. CD4+ T cell-independent vaccination against Pneumocystis carinii in mice. J. Clin. Invest. 108, 1469\u20131474 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnm1086_CR39","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ymthe.2003.08.022","volume":"8","author":"RG Pergolizzi","year":"2003","unstructured":"Pergolizzi, R.G. et al. In vivo trans-splicing of 5\u2032 and 3\u2032 segments of pre-mRNA directed by corresponding DNA sequences delivered by gene transfer. Mol. Ther. 8, 999\u20131008 (2003).","journal-title":"Mol. Ther."},{"key":"BFnm1086_CR40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/357080a0","volume":"357","author":"RJ Armitage","year":"1992","unstructured":"Armitage, R.J. et al. Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80\u201382 (1992).","journal-title":"Nature"},{"key":"BFnm1086_CR41","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1128\/MCB.8.5.2159","volume":"8","author":"J Field","year":"1988","unstructured":"Field, J. et al. Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol. Cell. Biol. 8, 2159\u20132165 (1988).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm1086_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/mthe.2000.0238","volume":"3","author":"K Xu","year":"2001","unstructured":"Xu, K., Ma, H., McCown, T.J., Verma, I.M. & Kafri, T. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol. Ther. 3, 97\u2013104 (2001).","journal-title":"Mol. Ther."},{"key":"BFnm1086_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.272.5259.263","volume":"272","author":"L Naldini","year":"1996","unstructured":"Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263\u2013267 (1996).","journal-title":"Science"},{"key":"BFnm1086_CR44","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463\u20138471 (1998).","journal-title":"J. Virol."},{"key":"BFnm1086_CR45","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/blood.V74.3.930.930","volume":"74","author":"SJ Szilvassy","year":"1989","unstructured":"Szilvassy, S.J., Lansdorp, P.M., Humphries, R.K., Eaves, A.C. & Eaves, C.J. Isolation in a single step of a highly enriched murine hematopoietic stem cell population with competitive long-term repopulating ability. Blood 74, 930\u2013939 (1989).","journal-title":"Blood"},{"key":"BFnm1086_CR46","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1006\/mthe.2002.0542","volume":"5","author":"E Vigna","year":"2002","unstructured":"Vigna, E. et al. Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol. Ther. 5, 252\u2013261 (2002).","journal-title":"Mol. Ther."},{"key":"BFnm1086_CR47","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/76095","volume":"25","author":"A Follenzi","year":"2000","unstructured":"Follenzi, A., Ailles, L.E., Bakovic, S., Geuna, M. & Naldini, L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25, 217\u2013222 (2000).","journal-title":"Nat. Genet."},{"key":"BFnm1086_CR48","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/80498","volume":"6","author":"T Kikuchi","year":"2000","unstructured":"Kikuchi, T., Worgall, S., Singh, R., Moore, M.A. & Crystal, R.G. Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells. Nat. Med. 6, 1154\u20131159 (2000).","journal-title":"Nat. Med."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1086","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:02:58Z","timestamp":1684447378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,25]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["BFnm1086"],"URL":"https:\/\/doi.org\/10.1038\/nm1086","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,25]]}}}